Clinical Trials

Myasthenia Gravis

NCT06788509 2026-04-13

A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring

GenitourinaryLymphoidMyeloidOther hematologic neoplasm

120 enrolled

Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Acute, Prostatic Neoplasms, Castration-Resistant

NCT06940648 2026-04-13

VIABLE

Genitourinary

Urinary Bladder Neoplasms

NCT07296263 2026-04-13

Contrast PMR

85 enrolled

Infections

NCT06709040 2026-04-06

A Study to Follow Paediatric Participants With Growth Hormone Deficiency Treated With Somapacitan for Long Term Safety Information and Clinical Parameters

500 enrolled

Endocrine

Diabetes Mellitus, Type 2, Dwarfism, Pituitary, Neoplasms

NCT07503613 2026-04-06

Long Term Follow-up Study of AAVAnc80-antiVEGF Gene Therapy

100 enrolled

Phase 2/3 Enrolling by invitation

Neuroma, Acoustic, Hearing Loss

NCT06506955 2026-04-03

Futibatinib in Patients Previously Enrolled in an Antecedent Futibatinib as Monotherapy or Combination Therapy.

15 enrolled

Neoplasm Metastasis, Cholangiocarcinoma

NCT05303532 2026-03-24

ROSY-D

214 enrolled

Tumor-Agnostic

Neoplasms

NCT06763965 2026-03-23

Evaluating the Safety and Efficacy of BioTTT001 in Patients With Recurrent/Progressive High-grade Glioma.

Adenoviridae Infections, Glioma

NCT07126990 2026-03-23

Clinical Study of a Novel Oncolytic Virus Ad-TD-nsIL12 in the Treatment of Primary High-grade Glioma

Glioma

NCT07218003 2026-03-23

A Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4

BreastGastrointestinalGenitourinaryGynecologicThoracic

149 enrolled

Esophageal Squamous Cell Carcinoma, Adenocarcinoma, Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Neoplasms, Stomach Neoplasms, Triple Negative Breast Neoplasms

NCT07226180 2026-03-18

Development and Application of Patient-Derived Models of Cancer

Tumor-Agnostic

Neoplasms

NCT07474051 2026-03-16

PERSIST

GenitourinaryLymphoidOther hematologic neoplasm

178 enrolled

Prostatic Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Acute, Lymphoma, B-Cell, Hematologic Neoplasms

NCT05332054 2026-03-12

LTFS

LymphoidOther hematologic neoplasmPlasma cell

150 enrolled

Lymphoma, Lymphoma, Non-Hodgkin, Multiple Myeloma, Leukemia, Myeloid, Acute, Lymphoma, B-Cell, Hematologic Neoplasms

NCT05041309 2026-02-25

Long-term Follow-up Study for Participants of Kite-Sponsored Interventional Studies Treated With Gene-Modified Cells

Other hematologic neoplasm

1,000 enrolled

Hematologic Neoplasms

NCT05441475 2026-02-25

A Phase 2, Open-Label Study of ABSK-011 Combined Atezolizumab or SOC in HCC Patients

118 enrolled

Carcinoma, Hepatocellular

NCT07158450 2026-02-25

NOECHO

50 enrolled

Heart Failure, Cardiotoxicity

NCT07116668 2026-02-18

SAFE-3CV

108 enrolled

Colorectal Neoplasms

NCT07417774 2026-02-18

RESTORE LB

Glioblastoma

NCT06701201 2026-02-10

A Long-Term Follow-Up Basket Study for Participants Treated With SynKIR Chimeric Antigen Receptor (CAR) T Cell Product

Phase 2/3 Enrolling by invitation

60 enrolled

Tumor-Agnostic

Neoplasms

NCT05374590 2026-02-02

ADAPT Jr +

Myasthenia Gravis

NCT07376629 2026-01-29

A Study of HB0025 Plus Nab-paclitaxel as First Line Therapy for TNBC

60 enrolled

Breast

TNBC

NCT05645536 2026-01-12

Safety Extension Study for Subjects With HR+, HER2- Breast Cancer for Subjects Who Have Completed the OVELIA Study

250 enrolled

Breast

Breast Neoplasms, Neoplasms

NCT06848088 2026-01-12

A Study to Learn About the Long-Term Health of Adult Participants From a Previous Study of a New Melanoma Treatment

Phase EARLY_PHASE1 Enrolling by invitation

48 enrolled

Dermatologic

Melanoma

NCT07316361 2026-01-07

GYNORYLAQ™

Gynecologic

Endometrial Neoplasms

NCT04770571 2025-12-22

Posterior Cervical Fixation Study

150 enrolled

Klippel-Feil Syndrome, Radiculopathy, Thoracic Injuries, Trauma, Nervous System, Intervertebral Disc Degeneration

NCT06281964 2025-12-16

KANNON-2

Phase EARLY_PHASE1 Enrolling by invitation

327 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07285434 2025-12-16

Microlyvaq™

90 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT06215846 2025-11-26

A Clinical Study Evaluating the Safety and Efficacy of BioTTT001 in Patients With Malignant Solid Tumors

Adenoviridae Infections

NCT06603987 2025-11-19

Using CICS-1 and SPM-011 and ［18F］FBPA Commissioned by CICS and Sumitomo Heavy Industries and STELLA PHARMA

BreastGastrointestinalOther solid neoplasmSarcomaThoracic

Mesothelioma, Malignant, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Neurofibrosarcoma

NCT02270567 2025-11-13

RegisterNET

400 enrolled

EndocrineNET

Carcinoid Tumor, Carcinoma, Neuroendocrine, Neuroendocrine Tumors, Disease Progression

NCT04093570 2025-10-31

A Study for Participants Who Participated in Prior Clinical Studies of ASTX727 (Standard Dose)

MyeloidOther hematologic neoplasm

332 enrolled

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic

NCT06544798 2025-10-16

Long-term Follow-up of Gene Therapy for Radiation-Induced Xerostomia

276 enrolled

Lymphoid

Lymphoma, Follicular

NCT07210047 2025-10-07

Study of HuL001 in Relapsed/Refractory Multiple Myeloma Patients

21 enrolled

Plasma cell

Multiple Myeloma

NCT05423977 2025-09-30

Study of ZV0203 in Patients With HER2-Positive Advanced Solid Tumors

36 enrolled

Other solid neoplasm

HER2-positive Advanced Solid Tumor

NCT06674538 2025-09-22

Clinical Trial to Treat Stage IV Cancer Patients

Sarcoma

Neoplasms, Sarcoma

NCT06945640 2025-09-16

HTK_002

80 enrolled

Genitourinary

Kidney Neoplasms

NCT06936527 2025-09-03

XS-03-II201

102 enrolled

Colorectal Neoplasms

NCT06208878 2025-08-14

A Long-term Follow-up Study of Subjects Who Received CRISPR CAR T Cellular Therapies

Other hematologic neoplasm

70 enrolled

Hematologic Neoplasms

NCT03628612 2025-08-07

Long-term Follow-up of Patients Treated With Genetically Modified Autologous T Cells

500 enrolled

LymphoidPlasma cell

Multiple Myeloma, Lymphoma, T-Cell

NCT06727032 2025-08-03

BrainMets AI

Brain Neoplasms

NCT06391749 2025-07-16

K-ACCELERATE

BreastGastrointestinalThoracic

1,000 enrolled

Breast Neoplasms, Colonic Neoplasms, Liver Neoplasms, Lung Neoplasms, Stomach Neoplasms

NCT06885424 2025-07-15

DESCENT-1

BreastGastrointestinalGenitourinaryGynecologicHead & NeckOther solid neoplasmThoracic

400 enrolled

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Head and Neck Neoplasms, Kidney Neoplasms, Mesothelioma, Ovarian Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

NCT07061769 2025-07-11

Helping Cancer Patients Manage Neuropathy Symptoms From Chemotherapy With a Low-Intensity, Low-Risk Cranial PEMF Device

50 enrolled

Chemotherapy Induced Peripheral Neuropathy

NCT07053904 2025-07-08

Phase I Open-Label Study of P1101 Followed by P1801 in Advanced Solid Tumors

54 enrolled

Other solid neoplasm

Advanced Solid Tumors

NCT07046832 2025-07-02

Clinical Evaluation of an Augmented Reality Intraprocedural Needle Guidance Platform for Soft Tissue Biopsy

GastrointestinalGenitourinary

104 enrolled

Carcinoma, Renal Cell, Carcinoma, Hepatocellular, Neoplasms

NCT06992687 2025-05-28

A Study to Evaluate the Safety and Efficacy of HB0052 in Patients With Advanced Solid Tumors

Other solid neoplasm

Solid Tumors

NCT06925685 2025-04-13

Follow-Up for Study Participants Treated With an Allogeneic CAR T-Cell Product

Other hematologic neoplasm

50 enrolled

Hematologic Neoplasms

NCT04915495 2025-03-21

The Use of the LuViva Advanced Cervical Scan to Identify Women at High-Risk for Cervical Neoplasia